Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jan 04, 2017 $18.45 $19.24 $18.18 $18.90 113 765
Jan 03, 2017 $17.69 $18.25 $17.58 $18.12 164 840
Dec 30, 2016 $17.13 $17.21 $16.60 $16.95 140 123
Dec 29, 2016 $16.75 $16.99 $16.50 $16.67 110 015
Dec 28, 2016 $17.05 $17.20 $16.51 $16.66 129 959
Dec 27, 2016 $17.32 $17.60 $17.00 $17.06 82 513
Dec 23, 2016 $17.01 $17.32 $16.90 $17.25 92 086
Dec 22, 2016 $17.35 $17.46 $16.85 $17.05 115 239
Dec 21, 2016 $17.63 $18.31 $17.26 $17.35 163 572
Dec 20, 2016 $16.38 $17.16 $16.38 $17.08 176 571
Dec 19, 2016 $16.62 $16.70 $16.32 $16.52 155 475
Dec 16, 2016 $17.33 $17.65 $16.81 $17.05 160 755
Dec 15, 2016 $17.40 $17.47 $16.80 $17.31 154 531
Dec 14, 2016 $17.94 $18.35 $17.42 $17.43 107 319
Dec 13, 2016 $17.65 $18.52 $17.65 $18.25 93 955
Dec 12, 2016 $17.72 $17.93 $17.17 $17.63 119 089
Dec 09, 2016 $17.17 $17.55 $17.17 $17.52 44 279
Dec 08, 2016 $17.36 $17.45 $16.63 $17.15 126 537
Dec 07, 2016 $17.87 $18.00 $17.27 $17.47 159 805
Dec 06, 2016 $17.85 $17.90 $17.05 $17.29 160 051
Dec 05, 2016 $17.08 $17.57 $17.01 $17.22 77 074
Dec 02, 2016 $16.67 $17.22 $16.67 $17.00 92 720
Dec 01, 2016 $17.09 $17.09 $16.09 $16.40 129 636
Nov 30, 2016 $17.69 $17.69 $16.86 $16.86 78 184
Nov 29, 2016 $17.62 $17.99 $17.60 $17.62 172 133
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT